Clinical trial
A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant
NCT06867952 is registered in ClinicalTrials.gov with S.LAB (SOLOWAYS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant
- Lead sponsor
- S.LAB (SOLOWAYS)
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 3, 2024
- Completion date
- March 3, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteopenia, osteoporosis